نتایج جستجو برای: chelation

تعداد نتایج: 4658  

2012
John Porter Donald K. Bowden Marina Economou Jacques Troncy Arnold Ganser Dany Habr Nicolas Martin Adam Gater Diana Rofail Linda Abetz-Webb Helen Lau Maria Domenica Cappellini

Treatment of iron overload using deferoxamine (DFO) is associated with significant deficits in patients' health-related quality of life (HRQOL) and low treatment satisfaction. The current article presents patient-reported HRQOL, satisfaction, adherence, and persistence data from β-thalassemia (n = 274) and myelodysplastic syndrome (MDS) patients (n = 168) patients participating in the Evaluatio...

Journal: :The Journal of Physiology 2021

Key points Iron acts as a cofactor in the stabilization of hypoxic-inducible factor family, and plays an influential role modulation hypoxic pulmonary vasoconstriction. It is uncertain whether iron regulation altered lowlanders during either (1) ascent to high altitude, or (2) following partial acclimatization, when compared high-altitude adapted Sherpa. During 5050 m, rise artery systolic pres...

Journal: :Haematologica 2012
Norbert Gattermann Carlo Finelli Matteo Della Porta Pierre Fenaux Michael Stadler Agnes Guerci-Bresler Mathias Schmid Kerry Taylor Dominique Vassilieff Dany Habr Andrea Marcellari Bernard Roubert Christian Rose

BACKGROUND Reductions in transfusion requirements/improvements in hematologic parameters have been associated with iron chelation therapy in transfusion-dependent patients, including those with myelodysplastic syndromes; data on there reductions/improvements have been limited to case reports and small studies. DESIGN AND METHODS To explore this observation in a large population of patients, w...

Journal: :Journal of medical economics 2013
Edward P Armstrong Grant H Skrepnek Medha Sasane Susan M Snodgrass Samir K Ballas

OBJECTIVE This retrospective study evaluated iron chelating therapy (ICT) discontinuation and costs in Sickle cell disease (SCD) Medicaid recipients using healthcare claims from 2006-2010. METHODS Patients with ≥1 SCD diagnosis claim, ≥2 claims for deferoxamine (DFO) or deferosirox (DFX), and continuous enrollment ≥6 months prior to and 18 months following ICT initiation were included. Outcom...

2015
Valeria Pinto Manuela Balocco Ilaria Ambaglio Giorgio Derchi Luca Malcovati Gian Luca Forni

Patients with transfusion-dependent myelodysplastic syndromes (MDS) have an increased risk of cardiac events, due to both chronic anemia and iron overload. Here, we report the recovery of cardiac function after an intensive iron chelation therapy in a MDS patient who had developed heart failure due to iron overload.

Journal: :Hematology/Oncology and Stem Cell Therapy 2017

Journal: :Bioinorganic Chemistry and Applications 2003

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید